Patients treated with ide-cel, Abecma for relapsed/refractory multiple myeloma affecting the central nervous system had similar outcomes to matched patients with non-CNS multiple myeloma. Initial ...

Therapy-related B-lymphoblastic leukemia (B-ALL) following treatment for multiple myeloma is a rare occurrence ... was recently published in the Journal of Clinical and Translational Pathology.

Therapy-related B-lymphoblastic leukemia (B-ALL) following treatment for multiple myeloma is a rare occurrence ... Journal of Clinical and Translational Pathology. Journal of Clinical and ...

OGM provides a comprehensive genomic profile that can be used to support more precise prognostic risk stratification “Multiple myeloma is one of the most requested cancer types by customers ...

Approval cements daratumumab as a foundational therapy in newly diagnosed multiple myeloma and the only anti-CD38 antibody for all patient types in this setting Phase 3 CEPHEUS study shows significant ...

Some people with multiple myeloma get eye problems like blurred vision, swollen or bulging eyelids, dry or watery eyes, and even vision loss. You might hear your doctor refer to these as “ocular ...

Bispecific antibodies enhance immune response by targeting myeloma and immune cells, showing high efficacy in multiple myeloma treatment. Tecvvayli, Talvey, and Elrexfio demonstrate significant ...

If you’ve tried other multiple myeloma treatments and they’re not working, your doctor may suggest immunotherapy. One type of immunotherapy uses monoclonal antibodies made in a lab to boost ...

The blood cancer multiple myeloma, which involves infection-fighting plasma cells in the bone marrow, affects only about 1% of all cancers -- predominantly individuals over age 65. The disease ...

For decades, the diagnosis of multiple myeloma required evidence of end-organ damage characterized by myeloma-defining events (MDEs) known as CRAB: Diagnosis also required -- and still does -- the ...

He sought a second opinion at Fred Hutch Cancer Center, where a full body scan revealed that Crow had multiple myeloma. “I didn’t know what ... in a study where he was taking lenalidomide, an oral ...